10 Incretin agents, including dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists (GLP-1 RA), improve glucose control through several mechanisms, including the increase of glucose-dependent insulin secretion, decrease of gastric emptying, and reduction of postprandial glucagon secretion
Meet face to face with your local provider Review your health history, labs, and goals to determine the right plan
To compensate for this reduced absorption, oral semaglutide requires daily dosing and must be taken under strict conditions: on an empty stomach with no more than 4 ounces of plain water, with a mandatory 30-minute wait before consuming any food, beverages, or other oral medications
Key takeaways A key patent on semaglutide the GLP-1 sold as Ozempic and Wegovy just expired in India, and drugmakers there are already selling their own versions for as little as $14 a month